Marshall Wace’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Marshall Wace’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,608	Closed	-$49K	–	4082
2022 Q1	$49K	Buy	+16,608	New	+$36.6K	﹤0.01%	3247
2021 Q1	–	Sell	-43,218	Closed	-$339K	–	3019
2020 Q4	$339K	Sell	43,218 -606,782	-93%	-$5.36M	﹤0.01%	1617
2020 Q3	$6.6M	Hold	650,000	–	–	0.04%	422
2020 Q2	$6.51M	Hold	650,000	–	–	0.05%	402
2020 Q1	$6.4M	Buy	+650,000	New	+$6.41M	0.06%	310

Marshall Wace's TLMD Position: Q2 2022 in Review

Marshall Wace sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 16,608 shares — an estimated $49K sold.

Marshall Wace first reported a position in TLMD in Q1 2020 and held it in 5 quarters. The position peaked at $6.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Marshall Wace reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Marshall Wace sold 16,608 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $49K.
Marshall Wace first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
Marshall Wace's SOC Telemed, Inc. Class A Common Stock position peaked at $6.6M in Q3 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.